Advertisement

Topics

[Comment] Can the Antimicrobial Resistance Benchmark blaze a new trail?

07:57 EDT 13 Oct 2017 | The Lancet

A year has passed since the landmark declaration at the UN General Assembly on antimicrobial resistance (AMR), acknowledging the threat to people, animals, agriculture, and the environment.1 On Oct 12–13, 2017, a conference organised by the Wellcome Trust in partnership with the UK, Ghanaian, and Thai governments and the UN Foundation, in support of the work of the Antimicrobial Resistance Inter-Agency Coordination Group (IACG), aimed to accelerate efforts to tackle rising drug-resistant infections.

Original Article: [Comment] Can the Antimicrobial Resistance Benchmark blaze a new trail?

NEXT ARTICLE

More From BioPortfolio on "[Comment] Can the Antimicrobial Resistance Benchmark blaze a new trail?"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...